BACK TO OVERVIEW

Automating bioinformatics workflows and data

Company description

PipeBio is revolutionizing drug development by offering a no-code, cloud-based SaaS bioinformatics platform that accelerates the creation of therapeutics 10x faster. Their platform integrates configurable sequence and assay-data databases with a robust analytical engine for large NGS datasets, REST API, and intuitive visualization tools. Designed to structure data for machine learning and AI applications, PipeBio empowers the scientific community to optimize the development of antibodies and antibody-like therapeutics.

Why we invested

"Massive advances in genomics and exponentially decreasing costs of DNA sequencing have transformed biology into data science and created the perfect building blocks for novel and superior tools. PipeBio helps the scientific community to execute their workflows faster and cheaper than ever."

Martin Krag, Partner

Founders
Jannick Bendtsen
CEO
Connect
Connect
Owen Bodley
CTO
Connect
Connect

Work for

PipeBio

VERTICAL
Techbio & Bio
Country
Denmark
INvested in
Pre-Seed
2021
Collective contributions